semaglutide side effects sweating Does GLP-1 Cause Night Sweats? FDA Data and Facts Study Reveals Unknown GLP-1 Side

Last reviewed: June 7, 2026 Last updated: June 7, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

For obesity management, semaglutide is initiated at 0.25 mg weekly and titrated gradually to the target dose of 2.4 mg weekly to minimize gastrointestinal intolerance[14]

Stop eating when you feel satisfied, not stuffed

Sin embargo, personas que no tienen diabetes ni obesidad estn consumiendo el medicamento para bajar de peso de forma rpida, un hbito que preocupa a los mdicos y cientficos